Asset
Tranexamic acid
Palisade Bio Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05470387 | phase3 | terminated | 2022-06-28 | 2023-03-06 | Palisade Bio | A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection |
| NCT02836470 | phase2 | completed | 2019-10-01 | 2023-09-06 | Palisade Bio | A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection |
FDA applications (0)
This company has no applications containing this asset.